Ignite Creation Date:
2024-07-17 @ 11:05 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06498622
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-07-07
Brief Title:
Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab
Sponsor:
Anhui Provincial Hospital
Organization:
Anhui Provincial Hospital
Organization Data
Organization:
Anhui Provincial Hospital
Class:
OTHER_GOV
Study ID:
2023KY433
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Anhui Provincial Hospital
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None